.After a few years in biotech, Mike Quigley, Ph.D., is going back to the pharma crease, taking up the leading science location at Sanofi.Quigley is going to begin Sept. 30 as the French Big Pharma's primary medical policeman as well as international chief of analysis, Sanofi informed Brutal Biotech in an emailed statement.Quigley is actually substituting Frank Nestle, M.D., who left Sanofi this springtime surrounded by an international overhaul of the firm's R&D unit. Nestle, that devoted 8 years along with the pharma, jumped over to Deerfield Management, where he currently acts as a partner on the therapies team and CEO of the firm's healing exploration and also advancement procedures.
Quigley will join Sanofi coming from a San Francisco-based biotech that remains in stealth, according to his LinkedIn account. He's presently detailed as the company's founder, head of state as well as CEO.Since August 2021, Quigley has actually functioned as an endeavor partner at SV Health and wellness Investors, a healthcare fund manager with present financial investments in biotechs like BioAge, Cerevance, Dualitas Therapeutics as well as Nimbus Therapeutics, and many more. Quigley previously held the top area at Dualitas, a biotech that continues to be in secrecy, according to STAT.The soon-to-be Sanofi leader also recently helmed Therini Bio, an immunotherapy biotech operating to build therapies for neurodegenerative conditions steered through general problems.Just before devoting the final handful of years in biotech, Quigley possesses an also longer performance history in Large Pharma, very most just recently serving as Gilead's senior bad habit head of state of study biology until the summer months of 2021. Prior to that, he clocked in more than 4 years across several leadership jobs at Bristol Myers Squibb and worked as a medical supervisor at Johnson & Johnson's Janssen upper arm before that.Sanofi stated Quigley's mission in his brand-new function would be actually to "maximize our chance of success with superior partnerships around our institution and past, carrying best-in-class innovation as well as creating and also sourcing brand-new industry-leading skill along with a dedication to diversity," according to an interior memo acquired by STAT.